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Host inflammation alters the availability of nutrients
such as iron to limit microbial growth. However,
Salmonella enterica serovar Typhimurium thrives in
the inflamed gut by scavenging for iron with side-
rophores. By administering Escherichia coli strain
Nissle 1917, which assimilates iron by similar mech-
anisms, we show that this nonpathogenic bacterium
can outcompete and reduce S. Typhimurium coloni-
zation in mouse models of acute colitis and chronic
persistent infection. This probiotic activity depends
on E. coli Nissle iron acquisition, given that mutants
deficient in iron uptake colonize the intestine but do
not reduce S. Typhimurium colonization. Addition-
ally, the ability of E. coli Nissle to overcome iron
restriction by the host protein lipocalin 2, which
counteracts some siderophores, is essential, given
that S. Typhimurium is unaffected by E. coli Nissle
in lipocalin 2-deficient mice. Thus, iron availability
impacts S. Typhimurium growth, and E. coli Nissle
reduces S. Typhimurium intestinal colonization by
competing for this limiting nutrient.
INTRODUCTION
Salmonella enterica serovar Typhimurium (S. Typhimurium) is
one of the leading causes of acute gastroenteritis, which is char-
acterizedby inflammatory diarrhea. Although thenormal intestine
is largely inhabited by commensal microbes, which largely
include Bacteroides and Firmicutes, inflammation enhances the
colonization of S. Typhimurium and other Enterobacteriaceae
(Barman et al., 2008; Lawley et al., 2008; Lupp et al., 2007;
Stecher et al., 2007). Recent studies have shown that S. Typhi-
murium thrives in the inflamed gut because it can utilize unique
carbon and energy sources (Thiennimitr et al., 2011; Winter
et al., 2010) and is resistant to antimicrobial proteins that are
secreted by the host as part of the nutritional immune response
(Liu et al., 2012; Raffatellu et al., 2009). S. Typhimurium employs26 Cell Host & Microbe 14, 26–37, July 17, 2013 ª2013 Elsevier Inc.specialized transporters to acquire essential micronutrient
metals (Liu et al., 2012; Raffatellu et al., 2009), one of the most
important being iron (Crouch et al., 2008; Raffatellu et al.,
2009). Levels of free iron are extremely low in the host environ-
ment because of sequestration by host proteins, including
heme, ferritin, transferrin, and lactoferrin (Andrews and Schmidt,
2007). Additional mechanisms are employed by the host to
further limit iron availability during inflammation (Weinberg,
1984), including secretion of the hormone hepcidin, which pre-
vents the gut from absorbing iron from the bloodstream by inhib-
iting the iron transporter ferroportin 1 (Ganz, 2003).
When starved for iron, bacteria synthesize and export small-
molecule high-affinity iron chelators termed siderophores.
Enterochelin is a catecholate-type siderophore secreted by
all Enterobacteriaceae, including Salmonella and commensal
E. coli (Raymond et al., 2003), which is sufficient to overcome
the host’s iron limitation in a normal (noninflamed) environment.
However, during inflammatory responses, the host secretes lip-
ocalin 2, an antimicrobial peptide that sequesters ferric entero-
chelin, thereby limiting the growth of strains such as commensal
E. coli that rely solely upon enterochelin for siderophore-based
iron acquisition (Berger et al., 2006; Flo et al., 2004). Some path-
ogens evade this response by synthesizing additional side-
rophores that are not sequestered by lipocalin 2 (Fischbach
et al., 2006a). For instance, Salmonella can synthesize and
secrete salmochelin (Mu¨ller et al., 2009), a C-glucosylated deriv-
ative of enterochelin that is too large to fit into the enterochelin-
binding pocket of lipocalin 2 (Fischbach et al., 2006b; Hantke
et al., 2003).
Probiotics are commensal microorganisms that are believed
to exert beneficial effects on the host. Escherichia coli Nissle
1917 (E. coli Nissle, serotype O6:K5:H1) is a probiotic strain
that was originally isolated from a soldier who appeared resistant
to an outbreak of diarrhea (Nissle, 1959). E. coli Nissle has been
shown to establish persistent colonization of the intestine and
has been used to treat or prevent a variety of intestinal disorders
(Cukrowska et al., 2002; Kruis et al., 2004; Lodinova´-Za´dnikova´
and Sonnenborn, 1997; Mo¨llenbrink and Bruckschen, 1994; Nis-
sle, 1959), including acute enteritis (Henker et al., 2007), but the
mechanistic basis for its protective actions is unknown. Given
that salmochelin-mediated iron acquisition during inflammation
enhances S. Typhimurium colonization (Raffatellu et al., 2009),
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Figure 1. Probiotic E. coli Nissle 1917
Reduces S. Typhimurium Fecal Shedding
(A) The concentration of iron in fecal samples
collected from mock-infected (n = 4) or S.
Typhimurium-infected (n = 4) C57BL/6 mice
4 days postinfection. Bars represent geometric
means ± SD.
(B–D) 129X1/SvJ mice were infected with
S. Typhimurium and either untreated (B) or treated
with one dose of E. coliNissle wild-type (C) or tonB
mutant (D) three days postinfection. S. Typhimu-
rium (black circles), E. coli Nissle WT, or tonB
mutant (white circles) were enumerated in the
colonic contents.
(E) Ratio of colony-forming units (cfu) recovered
from fecal samples of mice infected with
S. Typhimurium that were untreated compared to
mice treated with one dose of either E. coli Nissle
WT or tonB mutant three days postinfection.
Ratios 2 days postinfection (i.e., 1 day before
treatment) and 22 days postinfection are shown.
Bars represent geometric means ± SD. Data are
representative of n = 2 experiments. STM,
S. Typhimurium; EcN, E. coli Nissle. **p% 0.01.
See also Figure S1 and Table S1.
Cell Host & Microbe
Probiotic and Pathogenic Bacteria Compete for Ironwe hypothesized that E. coli Nissle might protect the host by
utilizing similar mechanisms to compete with S. Typhimurium
for essential micronutrients.
A snapshot analysis of the E. coli Nissle genome revealed that
it shares many fitness properties found in uropathogenic E. coli
(UPEC) strains of the same serotype (Grozdanov et al., 2004).
Intriguingly, the E. coli Nissle genome appears to encode for
as many iron uptake systems as UPEC (Garcia et al., 2011), an
armament that notably includes salmochelin, the hydroxamate-
type siderophore aerobactin, the mixed-type siderophore yersi-
niabactin, and the hemin uptake transporter ChuA. Given that
redundancy in iron uptake promotes the growth of UPEC in the
bladder and the kidney (Garcia et al., 2011), we reasoned that
it may also contribute to E. coli Nissle colonization of the in-
flamed gut. To test the hypothesis that iron uptake mechanisms
are important for E. coli Nissle probiotic activity, we set out to
examine the effect of administering wild-type (WT) E. coli NissleCell Host & Microbe 14, 2or mutant derivatives deficient in iron
uptake on the course of S. Typhimurium
infection.
RESULTS
Probiotic E. coli Nissle 1917
Reduces S. Typhimurium Fecal
Shedding
Our prior studies indicated that S. Typhi-
murium must overcome iron limitation to
successfully infect the host (Crouch
et al., 2008; Raffatellu et al., 2009). First,
to confirm that iron limitation occurs
during S. Typhimurium infection, we
measured the concentration of iron in
the feces of mice 4 days postinfectionin an S. Typhimurium colitis model by inductively coupled
plasma mass spectrometry (ICP-MS). We found that the con-
centration of fecal iron in the absence of infection was approx-
imately 950 mg/kg (Figure 1A). In contrast, the concentration of
fecal iron was significantly reduced, on average, to 300 mg/kg
in mice infected with S. Typhimurium (Figure 1A), confirming
that infection results in limitation of this metal in the colonic
environment. To gain insight into the mechanism behind the
lower levels of intestinal iron, we determined the expression
of hepcidin and ferroportin 1 (Figure S1 available online).
Although hepcidin transcripts were highly abundant in the liver
of both mock-infected and S. Typhimurium-infected mice, the
expression of hepcidin was not upregulated during S. Typhimu-
rium infection (Figure S1). Nonetheless, we observed a modest,
but significant, downregulation of ferroportin 1 in the liver and
intestine of mice infected with S. Typhimurium, which should
have resulted in higher levels of intestinal iron due to its6–37, July 17, 2013 ª2013 Elsevier Inc. 27
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Figure 2. Intestinal Host Response in Mice with Persistent S. Typhimurium Infection
129X1/SvJ mice were infected with S. Typhimurium and were either left untreated or were treated with one dose of E. coli Nissle WT or tonB mutant 3 days
postinfection. Cecal samples were collected at 6 or 22 days postinfection.
(A) Blinded histopathology scores of cecal samples at 22 days postinfection. The score of individual mice (circles) and the geometric mean for each group (bars)
are indicated.
(B) A detailed scoring for the animals shown in (A) is provided. Each stacked column represents an individual mouse.
(C) Hematoxylin and eosin (H&E)-stained sections from representative animals for each group. Although E. coli Nissle WT had no effect on inflammatory cell
infiltration, mucosal integrity (assessed by cryptitis and surface erosions) was modestly improved.
(legend continued on next page)
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Figure 3. Growth of E. coli Nissle 1917
Strains in Iron-Rich and Iron-Limited Media
Growth of E. coli Nissle WT and the mutants in iron
uptake tonB or iroN fuyA iutA chuA (D4) was
determined.
(A, C, and E) Growth of E. coli Nissle WT and the
tonB mutant in Dulbecco’s modified Eagle’s me-
dium (DMEM)/F12 (A) or DMEM/F12 supplemented
with 10% fetal bovine serum (FBS) (C) or nutrient
broth (NB) supplemented with Dipyridyl (E).
(B, D, and F) Growth of E. coli Nissle WT and the D4
mutant in DMEM/F12 (B) or DMEM/F12 supple-
mented with 10% FBS with the absence (D) or
presence (F) of 1 mg/ml lipocalin 2 (Lcn2). Bacteria
were enumerated at 2, 5, and 8 hr postinoculation.
Bars represent the geometric means ± SD of at
least three experiments. STM, S. Typhimurium;
EcN, E. coli Nissle. *p% 0.05; **p% 0.01.
See also Figure S2 and Table S2.
Cell Host & Microbe
Probiotic and Pathogenic Bacteria Compete for Ironreduced intestinal absorption. However, mice infected with S.
Typhimurium also showed a significant weight loss and
reduced food uptake (Figure S1) (data not shown), which may
have contributed to the lower concentration of iron in the intes-
tine of infected mice (Figure 1A).
Once we established that intestinal iron was indeed limited
during S. Typhimurium infection, we assessed the effects of
E. coli Nissle administration on S. Typhimurium infection. First,
we utilized 129X1/SvJ mice, which develop chronic Salmonella
colitis with persistent infection (Lawley et al., 2008). To ensure
that all mice became highly colonized, we administered strepto-
mycin prior to infection as previously described (Barthel et al.,
2003; Lawley et al., 2008). Then, S. Typhimurium-infected mice
were observed for 3 weeks postinfection, and they exhibited
consistently high levels of fecal shedding of Salmonella (Fig-
ure 1B) as well as high levels of inflammation (Figure 2). Remark-
ably, a single therapeutic dose of WT E. coli Nissle administered
3 days after inoculation with S. Typhimurium was able to estab-(D) Transcript levels of Lcn2, Tnf-a, and Inf-g were determined in the ceca of 129X1/SvJ mice infecte
S. Typhimurium, and treated with either one dose of E. coliNissle WT (black bars) or tonBmutant (gray bars) 3
postinfection. Data are expressed as fold increase overmock-infectedmice. Bars represent the geometricme
L, lumen; M, mucosa; SM, submucosa. *p% 0.05; **p% 0.01.
Cell Host & Microbe 14, 2lish persistent colonization (Figure 1C) and
significantly reduce S. Typhimurium colo-
nization by more than two logs for the
duration of the study (Figures 1C, 1E,
and S1). To determine whether the benefi-
cial effect of E. coli Nissle is dependent
upon its ability to acquire iron, a mutation
was constructed in the tonB gene of
E. coli Nissle.
TonB provides the energy necessary
for the active transport of iron-laden
siderophores and heme (Braun and
Hantke, 2011). As expected, the in vitro
growth of E. coli Nissle tonB was equiv-
alent to that of WT E. coli in an iron-rich
media (Figures 3A and S2) or when tonBwas complemented in trans (Figure S2), but not in media
when iron was limited by the addition of serum (Figure 3C)
or iron chelation with 2,20-dipyridyl (Figure 3E). Strikingly,
E. coli Nissle tonB was still able to establish persistent colo-
nization when administered to 129X1/SvJ mice 3 days after
S. Typhimurium infection but was unable to reduce the
S. Typhimurium burden in the feces (Figures 1D, 1E, and
S1). Moreover, only WT E. coli Nissle was able to ameliorate
the chronic inflammation observed in these S. Typhimurium-
challenged mice at 22 days postinfection (Figure 2). Consis-
tent with this observation, transcript levels of Lcn2, which
encodes for lipocalin 2, and levels of the proinflammatory
cytokines Tnf-a and Ifn-g were reduced in the cecum by
WT E. coli Nissle, but not by the tonB mutant (Figure 2D).
Therefore, our results suggested that iron acquisition is impor-
tant for the probiotic activity of E. coli Nissle and for its ability
to compete with S. Typhimurium in the inflamed gut during
chronic infection.d with S. Typhimurium (white bars), infected with
days postinfection. Samples were collected 6 days
ans ± SD. STM,S. Typhimurium; EcN, E. coliNissle;
6–37, July 17, 2013 ª2013 Elsevier Inc. 29
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Figure 4. E. coli Nissle 1917 Requires Iron
Uptake Systems to Reduce S. Typhimurium
Intestinal Colonization
(A and B) C57BL/6 mice were infected with
S. Typhimurium alone or coadministered with WT
E. coliNissle, the tonBmutant, or the iroN fuyA iutA
chuA mutant (D4).
(C and D) C57BL/6 mice were infected with
S. Typhimurium alone (WT or iroN mutant) or
coadministered with WT E. coli Nissle, the tonB
mutant, or the tonBmutant complemented in trans
when indicated. cfu in colonic contents were
enumerated at 48 (A and C) and 96 (B and D) hr
postinfection. S. Typhimurium (black circles) and
E. coli Nissle (white circles) counts are shown.
Representative experiments of n = 2 are shown.
STM, S. Typhimurium; EcN, E. coli Nissle. *p %
0.05; **p% 0.01.
See also Figure S3.
Cell Host & Microbe
Probiotic and Pathogenic Bacteria Compete for IronGrowth of E. coli Nissle Strains in Iron-Rich
and Iron-Limited Media
Given that tonB mutations impede multiple iron acquisition
mechanisms, we constructed a mutant strain that lacked four
separate tonB-dependent iron transport systems that have
been shown to contribute to iron acquisition during UPEC urinary
tract infection (Garcia et al., 2011). The resulting strain, termed
E. coli Nissle D4, lacked the salmochelin receptor IroN, the aero-
bactin receptor IutA, the yersiniabactin receptor FuyA, and the
heme receptor ChuA (E. coliNissle iroN fyuA iutA chuA). Notably,
in contrast to the tonBmutant, E. coli Nissle D4 may acquire iron
via ferric enterochelin through the FepA receptor. However,
blockade of ferric enterochelin via lipocalin 2 should result
in growth inhibition. Therefore, we determined the growth of30 Cell Host & Microbe 14, 26–37, July 17, 2013 ª2013 Elsevier Inc.the E. coli Nissle D4 in rich media supple-
mented with serum and/or the enteroche-
lin scavenger lipocalin 2, as we previously
described (Raffatellu et al., 2009). As ex-
pected, the E. coli Nissle D4 grew as well
as WT E. coli in iron-rich media (Figures
3B and S2) and, in contrast to the E. coli
Nissle tonB (Figure 3C), in iron-rich media
supplemented with serum (Figure 3D),
which was consistent with effective iron
acquisition via ferric enterochelin. Howev-
er, this strain exhibited a significant
growth impairment in medium supple-
mented with the iron scavenger lipocalin
2 (Figure 3F). Furthermore, the growth in-
hibition by lipocalin 2 on the E. coli Nissle
D4 mutant was no longer observed when
ferric iron was added to the media in the
form of iron citrate (Figure S2) (Pressler
et al., 1988). Promisingly, the growth of
WTE. coliNisslewas not impaired by sup-
plementation with lipocalin 2 (Figures 3F
and S2). Altogether, these results sug-
gested that lipocalin 2 resistance medi-
ated by nonenterochelin high-affinity ironuptake mechanisms might allow E. coli Nissle to grow in the in-
flamed gut and reduce S. Typhimurium colonization.
E. coli Nissle 1917 Requires Iron Uptake Systems
to Reduce S. Typhimurium Intestinal Colonization
To further assess whether high-affinity iron transporters may
contribute to the probiotic effect of E. coli Nissle, we adminis-
tered WT E. coli Nissle or isogenic mutant strains deficient in
iron uptake to mice infected with S. Typhimurium in a model of
acute colitis. Specifically, C57BL/6 mice were administered
streptomycin 1 day prior to infection as previously described
(Barthel et al., 2003; Raffatellu et al., 2009). Then, mice were
infected with S. Typhimurium alone or coadministered with an
equal dose of E. coli Nissle WT or mutants (Figures 4 and S3).
Cell Host & Microbe
Probiotic and Pathogenic Bacteria Compete for IronThen, colonization in the colon content was determined at 48, 72,
and 96 hr postinfection. In this model of acute colitis, the admin-
istration of E. coliNissle significantly reduced intestinal coloniza-
tion with S. Typhimurium at every time point (Figures 4A, 4B, and
S3). In contrast, neither the E. coliNissle tonB nor theD4mutants
were able to reduce intestinal S. Typhimurium colonization (Fig-
ures 4A, 4B, and S3) despite successfully establishing intestinal
colonization (Figures 4A, 4B, and S3). Notably, although E. coli
Nissle WT outgrew S. Typhimurium, both E. coli Nissle tonB
and the D4 mutant were outcompeted by S. Typhimurium at
96 hr postinfection (see also Figure 7). Moreover, complementa-
tion of E. coli Nissle tonB in trans partly rescued this strain’s
capability to reduce S. Typhimurium colonization (Figures 4C,
4D, and S3).
To gain additional insight into the competition for iron between
S. Typhimurium and E. coli Nissle in the inflamed gut, we tested
whether E. coli Nissle would affect the colonization of an
S. Typhimurium strain lacking the IroN receptor (iroN mutant),
which cannot acquire iron via salmochelin (Raffatellu et al.,
2009) (Figure S2). We have previously shown that an S. Typhimu-
rium iroN mutant has a colonization defect in the inflamed gut
that is dependent on the expression of lipocalin 2 (Raffatellu
et al., 2009). Consistent with our earlier study, we found that
an S. Typhimurium iroN mutant showed a defect in colonization
when compared to S. TyphimuriumWT (Figures 4C, 4D, and S3).
Consistent with our present study, administration of E. coliNissle
did not reduce the colonization of the S. Typhimurium iroN
mutant, supporting the notion that competition for iron is an
essential trait of its probiotic activity (Figures 4C, 4D, and S3).
Notably, at 96 hr postinfection, the colonization of the S. Typhi-
murium iroN mutant further decreased because of the higher
levels of lipocalin 2 (Figures 4D and S3C). In contrast, the down-
regulation of lipocalin 2 caused by the administration of E. coli
Nissle partly rescued the iroNmutant, whichwas still significantly
lower than WT S. Typhimurium at this time point. This was
consistent with our previously published results showing that
the iroN mutant is rescued in Lcn2/ mice (Raffatellu et al.,
2009). Altogether, these results demonstrate that iron uptake is
crucial for the beneficial effect of E. coli Nissle in reducing the
colonization of S. Typhimurium.
Next, given that E. coli Nissle was able to diminish the intesti-
nal burden ofS. Typhimurium, we analyzedwhether the probiotic
strain also ameliorated the intestinal inflammation caused by
S. Typhimurium in the acute colitis model (Figures 5 and S4).
The administration of E. coli Nissle alone did not cause intestinal
inflammation (Figures 5 and S4). Intriguingly, the addition of WT
E. coli Nissle, E. coli Nissle tonB, or E. coli Nissle D4 each
resulted in similar reductions of intestinal inflammation in S. Ty-
phimurium-infected C57BL/6 mice (Figures 5A, 5B, 5D, 5E,
and S4). In accordance with the reduction in inflammation,
decreased transcript levels of Lcn2, the neutrophil chemoattrac-
tant Cxcl-1, and the proinflammatory cytokine Il-17a were also
observed (Figures 5C and 5F). To determine whether E. coli Nis-
sle has direct anti-inflammatory effects, we administered
dextran sodium sulfate (DSS) to mice in the drinking water as a
means of inducing colitis in the absence of a bacterial infection
(Wirtz et al., 2007). Then, these mice were administered a single
dose of E. coli Nissle. Similar to E. coli Nissle administration dur-
ing S. Typhimurium infection, treatment with E. coli NissleCreduced the expression of proinflammatory cytokines in DSS-
treated mice (Figure S4). On the basis of these results, it appears
that E. coli Nissle exerts beneficial effects on cecal inflammation
during acute Salmonella colitis that are independent of its antag-
onism of S. Typhimurium colonization.
The host inflammatory response limits iron availability to
invading microbes in what is known as nutritional immunity
(Cassat and Skaar, 2013). One arm of the nutritional immune
response during infection is the upregulation of lipocalin 2,
which, as described earlier, sequesters iron-bound enterochelin.
Previously, we demonstrated that the ability to acquire iron
through salmochelin provides a colonization advantage to
S. Typhimurium WT in competition with an iroN mutant in mice
that express lipocalin 2, but not in Lcn2/ mice, most likely
because enterochelin alone is sufficient to overcome other
mechanisms of ferric iron restriction in the host (Raffatellu
et al., 2009). Consistent with this notion, intestinal S. Typhimu-
rium colonization inWTmice was not affected by the administra-
tion of a nonprobiotic commensal E. coli strain (Figure 6A) that
relies on enterochelin for ferric iron acquisition and, thus, is
susceptible to lipocalin 2 (Berger et al., 2006; Flo et al., 2004).
Therefore, we hypothesized that E. coli Nissle would lose its
competitive advantage over S. Typhimurium in the absence of
lipocalin 2. As predicted, intestinal S. Typhimurium colonization
in Lcn2/ mice was not decreased by the administration of
E. coli Nissle, despite successful colonization of the mouse
intestine by this probiotic strain (Figure 6B). As we previously
showed, WT and Lcn2/ mice infected with S. Typhimurium
did not show significant differences in S. Typhimurium coloniza-
tion (Figures 4, 6B, and S3) or inflammation (Figures S4 and S5).
Furthermore, the expression of proinflammatory cytokines was
similar betweenWTmice and Lcn2/mice, the exception being
Cxcl-1, which was reduced in Lcn2/ mice, as previously
shown for Cxcl-8 (Bachman et al., 2009). Nonetheless, reduction
in the expression of Cxcl-1 did not result in differences in the
neutrophil influx observed by the pathology, most likely because
of redundant mechanisms of neutrophil migration to the gut (light
blue bars, Figures S4 and S5). Notably, the administra-
tion of E. coli Nissle to Lcn2/ mice infected with S. Typhimu-
rium also ameliorated intestinal inflammation, despite
the minimal differences observed in the expression of proinflam-
matory cytokines. These results may indicate that lipocalin 2
has additional immunomodulatory effects that are independent
of its iron sequestration mechanisms (Bachman et al., 2009).
Although we had administered E. coli Nissle as a therapeutic
either during or after S. Typhimurium administration, this strain
was originally isolated as a normal commensal of the gut flora
from a healthy soldier who did not acquire Shigella during an
outbreak. To test whether colonization of mice with E. coli
Nissle would confer protection to infection, C57BL/6 mice
were administered E. coli Nissle 3 days prior to S. Typhimurium
infection. As shown in Figure 6C, mice that were precolonized
with E. coli Nissle showed a significant reduction in colonization
from S. Typhimurium, indicating that colonization with this
probiotic offers at least partial protection to infection with a
gastrointestinal pathogen.
Next, we determined the ratio of the S. Typhimurium colony-
forming units (cfu) detected in the colonic content of C57BL/6
mice when S. Typhimurium was administered alone versusell Host & Microbe 14, 26–37, July 17, 2013 ª2013 Elsevier Inc. 31
AC
D
F
E
B Figure 5. E. coli Nissle 1917 Ameliorates In-
testinal Inflammation during Acute S. Typhi-
murium Infection
(A) Blinded histopathology scores of cecal
samples 4 days postinfection of C57BL/6 mice
administered WT E. coliNissle, S. Typhimurium, or
a mixture of S. Typhimurium and E. coli Nissle WT
or tonB mutant. Scores of individual mice (circles)
and geometric means for each group (bars) are
indicated.
(B) H&E-stained sections from representative
animals for each group. E. coli Nissle WT or tonB
coadministration with S. Typhimurium reduced
the density of inflammatory infiltrates (black
asterisks) and the degree of crypt injury (white
asterisks) in comparison to S. Typhimurium
infection alone.
(C) Transcript levels of Lcn2, Cxcl-1, and Il-17a
were determined in the ceca of C57BL/6 mice
infected with S. Typhimurium (white bars), a
mixture of S. Typhimurium and WT E. coli Nissle
(black bars), or a mixture of S. Typhimurium
and E. coli Nissle tonB (gray bars). Data
are expressed as fold increase over mock-
infected mice. Bars represent the geometric
means ± SD.
(D) Blinded histopathology scores of cecal sam-
ples 4 days postinfection of mice administered
E. coli Nissle iroN fuyA iutA chuA (D4), S. Typhi-
murium, or a mixture of S. Typhimurium and E. coli
Nissle D4. Scores of individual mice (circles)
and geometric means for each group (bars) are
indicated.
(E) H&E-stained sections from representative
animals from each group. E. coli Nissle D4
coadministration with S. Typhimurium greatly
reduced chronic inflammatory infiltrates (black
asterisks) and the degree of crypt injury (white
asterisks) in comparison to S. Typhimurium
infection alone.
(F) Transcript levels of Lcn2, Cxcl-1, and Il-17a
were determined in the ceca of mice infected with
S. Typhimurium (white bars) or a mixture of S.
Typhimurium and E. coli Nissle D4 (gray bars).
Data are expressed as fold increase over mock-
infected mice. Bars represent geometric means ±
SD. STM, S. Typhimurium; EcN, E. coli Nissle. L;
lumen; M, mucosa; SM, submucosa. *p % 0.05;
**p% 0.01.
See also Figure S4 and Table S3.
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Probiotic and Pathogenic Bacteria Compete for Ironin competition with E. coli Nissle. Overall, there was a marked
reduction (up to 445-fold) in S. Typhimurium fecal colonization
in WT mice that were coadministered WT E. coli Nissle at the
time of infection relative to mice that were infected with
S. Typhimurium only, a difference which was not observed in
either Lcn2/ mice or WT mice that were administered either
the E. coli Nissle tonB or the E. coli Nissle D4 mutants (Figures
7A, 7C, and 7E). Furthermore, only WT E. coli Nissle
coadministered with S. Typhimurium to WT mice was able
to outcompete S. Typhimurium by up to 195-fold (Figures
7B, 7D, and 7F). Altogether, our results show that iron acquisi-
tion in the inflamed gut is a critical mechanism for the ability of
the probiotic E. coli Nissle to limit Salmonella intestinal
colonization.32 Cell Host & Microbe 14, 26–37, July 17, 2013 ª2013 Elsevier Inc.DISCUSSION
E. coliNissle was isolated from a healthy soldier during a Shigella
outbreak in 1917 under the hypothesis that a protective
commensal strain must have colonized the gut of that soldier
(Nissle, 1959). In the years since, E. coliNissle has had a long his-
tory of use in clinical settings to treat gastrointestinal disorders,
though the molecular mechanism of its beneficial activity is not
well understood (Schultz, 2008), much like all natural probiotics
(reviewed in Balakrishnan and Floch, 2012).
Probiotics may exert their beneficial effects by either direct
interaction with the host or by competition with pathogenic
species (mechanisms frequently grouped under the term colo-
nization resistance) (reviewed in Lawley and Walker, 2013). A
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Figure 6. E. coli Nissle 1917 Reduction of
S. Typhimurium Intestinal Colonization
Requires Functional Lipocalin 2 and Is Inde-
pendent of the Time of Administration
(A) C57BL/6 mice were infected with S. Typhimu-
rium alone or coadministered with commensal
E. coli K-12. cfu in colonic contents were
enumerated at 48, 72, and 96 hr postinfection.
STM (black circles) and E. coli K-12 (white circles)
counts are shown.
(B) C57BL/6 Lcn2/ mice were infected with
S. Typhimurium alone or coadministered with WT
E. coli Nissle. cfu in colonic contents were
enumerated at 48, 72, and 96 hr postinfection.
S. Typhimurium (black circles) and E. coli Nissle
(white circles) counts are shown.
(C) C57BL/6 mice were administered a single dose
of E. coli Nissle WT or mock 3 days before
being infected with S. Typhimurium. Streptomycin
treatment was performed one day prior to
S. Typhimurium infection. cfu in colonic contents
were enumerated at 2, 3, and 4 days postinfection.
S. Typhimurium (black circles) and E. coli Nissle
(white circles) counts are shown. K12, E. coli K12;
STM, S. Typhimurium; EcN, E. coli Nissle.
See also Figure S5.
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Probiotic and Pathogenic Bacteria Compete for Ironlarge focus of research on probiotics has been on their interac-
tions with the immune system rather than their competition with
other microbes. Regarding E. coli Nissle, several studies have
proposed that selective immune modulation may contribute
to its activity (reviewed in Behnsen et al., 2013, and Jacobi
and Malfertheiner, 2011), including the activation of gd T cells
(Guzy et al., 2008), reduction of the secretion of proinflamma-
tory cytokines in the mucosa (Grabig et al., 2006), enhanced
secretion of IgA and IgM (Cukrowska et al., 2002), and produc-
tion of tight junction proteins (Ukena et al., 2007) and human
b-defensin 2 (Wehkamp et al., 2004). Although E. coli Nissle
has been proposed to have both pro- and anti-inflammatory
effects, the net result of these alterations is an overall enhance-
ment of the mucosal barrier. Consistent with these findings, as
well as with other studies that have shown E. coli Nissle to
ameliorate the disease caused by an infection (Hockertz,
1997; Splichalova et al., 2011), we also observed a reduction
in both intestinal pathology and expression of proinflammatory
cytokines when S. Typhimurium-infected mice were adminis-
tered E. coli Nissle in both a chronic and an acute model of
infection, as well as when we induced inflammation indepen-
dent of infection.Cell Host & Microbe 14, 2The two mouse models that we
employed (129X1/SvJ for the chronic
model and C57BL/6 for the acute model)
develop intestinal inflammation when
infected with S. Typhimurium after strep-
tomycin treatment. However, the host
response to S. Typhimurium is not iden-
tical in these mice because of genetic
differences as well as differences in the
composition of the microbiota. Presently,
the most well-studied genetic distinctionis that 129X1/SvJ have a functional Nramp1 (Slc11a1) allele,
which renders the mice more resistant to infection with S. Typhi-
murium. However, functional Nramp1 alone does not explain
differences in the host response to S. Typhimurium (Brown
et al., 2013), and altered expression or function of other genes
(for instance, caspase 11) may also play a role (Kayagaki et al.,
2011). These variances may explain why in the chronic model
of infection only WT E. coli Nissle mediated a reduction of
inflammation, whereas in the acute model of infection the reduc-
tion was independent of iron acquisition. Nevertheless, our study
indicates that the mild-to-moderate reduction in intestinal
inflammation only partly explains the beneficial effects of admin-
istering E. coli Nissle during infection.
Intestinal inflammation of infectious and noninfectious origins
results in an alteration of the normal flora and a significant micro-
bial dysbiosis, including the loss of Bacteroidetes and Firmicutes
and the proliferation of Enterobacteriaceae (reviewed in Fava
and Danese, 2011, and Mukhopadhya et al., 2012). A mecha-
nism for the proliferation of Enterobacteriaceae in the inflamed
gut was recently provided by Winter et al. (2013), who showed
that this family can utilize host-derived nitrate for respiration.
The fact that E. coli Nissle also benefits from inflammation could6–37, July 17, 2013 ª2013 Elsevier Inc. 33
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Figure 7. Ratios of S. Typhimurium and
E. coli Nissle in the Acute Colitis Model
Ratio of the cfu recovered from the fecal samples
of mice infected with S. Typhimurium that were
untreated in comparison to mice that were admin-
istered one dose of either E. coli Nissle WT, the
tonBmutant, or the iroN fuyA iutA chuA (D4) mutant
at the time of infection.
(A, C, and E) Ratio of S. Typhimurium cfu at 48 (A),
72 (C), or 96 (E) hr postinfection.
(B, D, and F) Competitive index (CI) in the indicated
mixed infection was calculated by dividing the
output ratio (E. coli Nissle cfu / S. Typhimurium cfu)
in the colonic contents of mice at the indicated
time points by the input ratio (E. coli Nissle cfu /
S. Typhimurium cfu). CI of the indicated E. coli
Nissle strain versus S. Typhimurium at 48 (B), 72
(D), or 96 hr (F) postinfection. Bars represent geo-
metric means ± SD. *p% 0.05; **p% 0.01.
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Probiotic and Pathogenic Bacteria Compete for Ironalso explain why its anti-inflammatory effects are mild to moder-
ate: a complete reduction of inflammation would be detrimental
to its own colonization, as indicated in our mice that were pre-
colonized with E. coli Nissle prior to S. Typhimurium infection.
A change in the composition of the normal flora, coupled with
a loss of Bacteroidetes and Firmicutes, is also observed during
infection caused by S. Typhimurium, given that this pathogen
has been shown to thrive during inflammation and successfully
compete with the microbiota (reviewed in Thiennimitr et al.,
2012). Whereas the host inflammatory response limits the avail-
ability of essential nutrients, including metal ions, to invading
microbes in what is known as nutritional immunity, pathogens
including Salmonella have evolved many mechanisms to evade
this response and acquire essential metals necessary to mount
a successful infection (Thiennimitr et al., 2012).
Our previous studies indicated that iron uptake via salmoche-
lin, which confers resistance to iron sequestration mediated by
lipocalin 2, is essential for the efficient colonization of S. Typhi-
murium (Crouch et al., 2008; Raffatellu et al., 2009). Given that34 Cell Host & Microbe 14, 26–37, July 17, 2013 ª2013 Elsevier Inc.the evasion of lipocalin 2-mediated iron
withholding has also been found to be
essential to the virulence of many other
Gram-negative enteric pathogens (Bach-
man et al., 2009; Caza et al., 2008; Garcia
et al., 2011; Himpsl et al., 2010; Payne
et al., 2006), this mechanism has come
to be viewed as a virulence trait. In
contrast to this trend, our research dem-
onstrates that lipocalin 2-resistant iron
acquisition is not a property unique to
virulence because it is essential for the
probiotic activity of E. coli Nissle.
Deletion of up to three iron receptors did
not result in a growth defect in media
supplemented with lipocalin 2 (data not
shown), indicating that E. coli Nissle pos-
sesses redundant lipocalin 2-resistant
iron uptake systems. Integrating this
finding with our observation that E. coliNissle outcompetes S. Typhimurium in vivo along with our previ-
ous finding that S. Typhimurium benefits from acquiring iron in a
lipocalin 2-resistant fashion during inflammation, we hypothe-
sized that Nissle’s multiple iron uptake systems provide a
competitive advantage against S. Typhimurium when the intes-
tine is inflamed, and, as we observed, fecal iron is significantly
reduced. Consistent with our hypothesis, our results show that
E. coli Nissle’s ability to displace the highly evolved pathogen
from its intestinal niche is dependent on iron acquisition. Further-
more, E. coli Nissle was only able to reduce the colonization of
S. Typhimurium when lipocalin 2 was expressed. Although lipo-
calin 2 is one of the host defenses exploited by S. Typhimurium
to colonize the inflamed gut and compete with the microbiota,
E. coliNissle also subverts this host defensemechanism to thrive
in the same inflamed and iron-starved environment. By scav-
enging for iron more effectively than S. Typhimurium both with
its own armament of siderophores and with its ability to compete
with S. Typhimurium for uptake of salmochelin, E. coli Nissle tips
the scales back in favor of the host, effectively augmenting the
Cell Host & Microbe
Probiotic and Pathogenic Bacteria Compete for Ironhost’s innate immune response by acting as a surrogate of sorts
for lipocalin 2. It is along these lines that we propose that E. coli
Nissle—and possibly other beneficial components of the micro-
biota—may provide colonization resistance in part by boosting
the host’s nutritional immunity, sequestering nutrients from
pathogens when the host fails to do so.
Altogether, our results show that iron acquisition in the in-
flamed gut is a critical mechanism for the ability of the probiotic
E. coli Nissle to limit Salmonella intestinal colonization. Further-
more, we have demonstrated that this action of E. coli Nissle re-
sults from its resistance to lipocalin 2, previously considered a
mechanism of virulence but now also seen as an essential prop-
erty of a protective commensal organism. As antibiotic treatment
is contraindicated for uncomplicated Salmonella infections due
to the prolongation of fecal shedding, the administration of
E. coliNissle may be a feasible alternative for diminishing Salmo-
nella colonization and ameliorating symptoms. As microbial dys-
biosis is apparent in a variety of intestinal disorders (DuPont and
DuPont, 2011), iron acquisition may also contribute to other pro-
biotic actions attributed to E. coliNissle. The ability of E. coliNis-
sle to withstand inflammation and outcompete a highly evolved
pathogen for an essential micronutrient may be seen as a para-
digm for understanding the protective actions of commensal mi-
croorganisms and a foundation upon which to build future probi-
otics tailored to the treatment of different diseases.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions
All strains used in this study are listed in Table S1. S. Typhimurium strain
IR715 is a fully virulent, nalidixic-acid-resistant derivative of WT isolate
ATCC 14028. Escherichia coli Nissle 1917 WT is a nonpathogenic human
E. coli isolate that we obtained from Ulrich Sonnenborn (Ardeypharm). An
IR715 derivative carrying a mutation in iroN and E. coli Nissle derivatives
carrying mutations in tonB or iroN, iutA, fyuA, and chuA were used for this
study. Mutant construction is described in the Supplemental Information,
and the plasmids and primers used are detailed in Tables S1 and S2. For
animal infections, all strains were grown in Miller Luria-Bertani (LB) media at
37C with aeration overnight.
In Vitro Growth Assays
S. Typhimurium and E. coli Nissle strains were tested for the ability to grow in
iron limiting conditions (nutrient broth supplemented with 0.2 mM 2,2-
Dipyridyl, Sigma-Aldrich) at 37C with aeration overnight. To test lipocalin 2
sensitivity, approximately 103 cfu from an overnight culture were inoculated
into tissue culture medium comprising DMEM/F12 (Invitrogen) plus 10% fetal
bovine serum (FBS, Invitrogen) or in the same medium containing human lip-
ocalin 2 (1 mg/ml, R&D Systems) as previously described (Raffatellu et al.,
2009). In order to compare general growth rates, a 1:1 mixture of E. coli Nissle
WT and either the tonB or the D4 mutants containing 1 3 107 cfu was inocu-
lated in M9 minimal media at 37C with aeration. When indicated, iron (III)
citrate and iron (III) sulfate were added at a final concentration of 1 mM and
200 mM, respectively. cfu were enumerated by plating serial dilutions at 2, 5,
and 8 hr after inoculation.
Animal Infections
All animal experiments were reviewed and approved by the Institutional Animal
Care and Use Committee at the University of California, Irvine. For acute
infections, female C57BL/6 (Taconic) and lipocalin 2-deficient (Lcn2/) mice
were orally gavaged with a dose of 109 cfu in 100 ml of PBS 24 hr after pre-
treatment with streptomycin (100 ml of a 200 mg/ml solution in sterile water)
(Barthel et al., 2003; Raffatellu et al., 2009). Mice were infected with either
S. Typhimurium alone or a 1:1 mixture of strains as indicated. Fecal pellets
were collected at 48 and 72 hr postinfection, weighed for cfu determi-Cnation, and homogenized in 1 ml of sterile PBS, and serial dilutions were
plated on LB agar containing appropriate antibiotics. At 96 hr postinfection,
mice were euthanized, and the cecum was collected for the isolation of
messenger RNA (mRNA) and for histopathology. The liver was collected
as indicated in order to measure hepatic gene expression. Bacteria were
enumerated in the colon content on agar plates containing the appropriate
antibiotics. To render all strains equally resistant to streptomycin, either
pACYomega or pHP45omega (Table S1) were introduced by electropora-
tion. When noted, the competitive indices were calculated by dividing
the output ratio (E. coli Nissle cfu / S. Typhimurium cfu) by the input
ratio (E. coli Nissle cfu / S. Typhimurium cfu). In some groups of mice, a
single dose of 109 cfu of E. coli Nissle was administered 3 days prior
to S. Typhimurium infection, as indicated. In other groups, colitis was
induced by administration of dextran sodium sulfate (Wirtz et al., 2007);
some of these mice were administered a single dose of 109 cfu E. coli Nissle
on the same day that DSS treatment was started (day 1). DSS-treated mice
were sacrificed on day 6, and the cecum was harvested for RNA purification
and analysis.
For chronic infections, female 129X1/SvJ mice (the Jackson Laboratory)
were orally gavaged as described above with S. Typhimurium 24 hr after
pretreatment with streptomycin (Lawley et al., 2008). 72 hr postinfection,
groups of mice were administrated a single dose of 109 cfu E. coli Nissle
WT or E. coli tonB mutant in 100 ml of LB by oral gavage. Individual
mice were followed for the duration of the experiment (up to 22 days). Fecal
pellets and colon contents were collected and processed as described
above.
Quantitative Real-Time PCR
For the analysis of gene expression by quantitative real-time PCR, total RNA
was extracted from cecal and hepatic tissues with TRI Reagent (Molecular
Research Center). For DSS-treated mice, oligo(dT) purification of mRNA was
performed with the Dynabeads mRNA Purification Kit (Invitrogen). Real-time
PCR was performed with SYBR Green (Roche) and the Roche LightCycler
480 System (Roche). Data were analyzed with the comparativeDD-Ct method.
Target gene transcription of each sample was normalized to the respective
levels of mRNA b-actin. A list of the real-time primers used in this study is pro-
vided in Table S3.
Histopathology
Tissue samples were fixed in formalin, processed according to standard pro-
cedures for paraffin embedding, sectioned at 5 mm, and stained with hematox-
ylin and eosin. Blinded examination by a board-certified pathologist was used
to score the pathology of cecal samples with previously published methods
(Barthel et al., 2003; Raffatellu et al., 2009). Each section was evaluated for
the presence of neutrophils, mononuclear infiltrate, submucosal edema, sur-
face erosions, inflammatory exudates, and cryptitis. Inflammatory changes
were scored from 0 to 4 according to the following scale: 0 = none, 1 = low,
2 = moderate, 3 = high, and 4 = extreme. The inflammation score for each
mouse was calculated by adding the score for each parameter and was inter-
preted as follows: 0–2 = within the normal limit, 3–5 = mild, 6–8 = moderate,
and 8+ = severe.
Measurement of Iron in Fecal Samples by ICP-MS
The amount of iron in mouse fecal samples was measured by ICP-MS as pre-
viously described (Corbin et al., 2008; Liu et al., 2012) and is detailed in the
Supplemental Experimental Procedures.
Statistical Analysis
The differences between treatment groups were analyzed by ANOVA followed
by a Student’s t test. A p value equal to or below 0.05 was considered statis-
tically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2013.06.007.ell Host & Microbe 14, 26–37, July 17, 2013 ª2013 Elsevier Inc. 35
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